Kendall Capital Management Purchases New Shares in HCA Healthcare, Inc. $HCA

Kendall Capital Management acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, HoldingsChannel reports. The fund acquired 3,585 shares of the company’s stock, valued at approximately $1,398,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Sumitomo Life Insurance Co. increased its position in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after acquiring an additional 20 shares in the last quarter. MJP Associates Inc. ADV grew its stake in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after purchasing an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its holdings in HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after buying an additional 21 shares in the last quarter. Anchyra Partners LLC increased its stake in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after buying an additional 21 shares during the period. Finally, Plato Investment Management Ltd lifted its stake in shares of HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after acquiring an additional 22 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on HCA. Raymond James Financial set a $528.00 price objective on HCA Healthcare in a report on Tuesday, July 7th. KeyCorp lowered their price target on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research report on Monday, July 27th. Argus reduced their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Stephens dropped their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Finally, Wells Fargo & Company lifted their price objective on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research note on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Stock Performance

HCA opened at $429.08 on Friday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The firm has a market cap of $92.90 billion, a PE ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. The firm’s fifty day moving average is $397.16 and its two-hundred day moving average is $444.14.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the prior year, the company earned $6.84 EPS. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. Equities analysts forecast that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is presently 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.